447 related articles for article (PubMed ID: 28394926)
1. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
Zhang X; Zhu C; Wang T; Jiang H; Ren Y; Zhang Q; Wu K; Liu F; Liu Y; Wu J
PLoS Pathog; 2017 Apr; 13(4):e1006321. PubMed ID: 28394926
[TBL] [Abstract][Full Text] [Related]
2. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
[TBL] [Abstract][Full Text] [Related]
3. microRNA-125a targets MAVS and TRAF6 to modulate interferon signaling and promote HCV infection.
Yan J; Zhang Y; Su Y; Tian L; Qin P; Xu X; Zhou Y
Virus Res; 2021 Apr; 296():198336. PubMed ID: 33577860
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
5. Golgi protein 73 facilitates the interaction of hepatitis C virus NS5A with apolipoprotein E to promote viral particle secretion.
Zhang X; Wang T; Dai X; Zhang Y; Jiang H; Zhang Q; Liu F; Wu K; Liu Y; Zhou H; Wu J
Biochem Biophys Res Commun; 2016 Oct; 479(4):683-689. PubMed ID: 27697522
[TBL] [Abstract][Full Text] [Related]
6. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
[TBL] [Abstract][Full Text] [Related]
7. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome.
Zhang L; Liu J; Qian L; Feng Q; Wang X; Yuan Y; Zuo Y; Cheng Q; Miao Y; Guo T; Zheng X; Zheng H
PLoS Pathog; 2018 May; 14(5):e1007067. PubMed ID: 29734366
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
9. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.
Shi Z; Zhang Z; Zhang Z; Wang Y; Li C; Wang X; He F; Sun L; Jiao S; Shi W; Zhou Z
J Biol Chem; 2015 Oct; 290(44):26811-20. PubMed ID: 26385923
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6.
Chan ST; Lee J; Narula M; Ou JJ
J Virol; 2016 Dec; 90(23):10928-10935. PubMed ID: 27681126
[TBL] [Abstract][Full Text] [Related]
11. CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection.
Liu Y; Zou Z; Zhu B; Hu Z; Zeng P
Int J Mol Sci; 2013 Dec; 14(12):24230-41. PubMed ID: 24351813
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infection.
Kar P; Kumar D; Gumma PK; Chowdhury SJ; Karra VK
J Med Virol; 2017 Dec; 89(12):2165-2172. PubMed ID: 28480979
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
15. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus reveals a novel early control in acute immune response.
Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF
PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264
[TBL] [Abstract][Full Text] [Related]
18. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
[TBL] [Abstract][Full Text] [Related]
19. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
[TBL] [Abstract][Full Text] [Related]
20. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
